← Back
Data updated: Mar 10, 2026
SOLIS PHARMS
Dermatology
SOLIS PHARMS is a generic drug manufacturer focused on Dermatology. Key products include FLUOXETINE HYDROCHLORIDE.
1979
Since
5
Drugs
-
Trials
43
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
PIROXICAM 2025-09-12
Labeling
FLUOXETINE HYDROCHLORIDE 2025-08-13
Labeling
FLUOXETINE HYDROCHLORIDE 2025-07-11
Manufacturing (CMC)
DAPSONE 2025-06-17
Labeling
FLUOXETINE HYDROCHLORIDE 2025-05-05
Manufacturing (CMC)
DAPSONE 2025-04-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (3)
Company Info
- First Approval
- 1979-01-26
- Latest
- 2025-04-23
- Applications
- 5